- | Country : -
- | organs : -
- | Specialty : -
Extract
To evaluate pharmacokinetics, safety, and efficacy of BAY 94-9027 for prophylaxis and treatment of bleeding in previously treated patients with hemophilia A Expansion group (Part 2) To further evaluate safety of BAY 94-9027 for prophylaxis and treatment of bleeding in PTPs with hemophilia A below 6 years of age.
Inclusion criteria
- Severe hemophilia A (< 1% FVIII:C)